Tag: covid
-
Revive Therapeutics (RVV.C) to have 10 clinical COVID-19 FDA trial sites by end of year
Earlier this year, when Revive Therapeutics (RVV.C) announced they had some pharma IP that may be relevant to the treatment of COVID-19, plenty of folks laughed uproariously at the thought that a three time loser might be relevant in 2020. Having missed on an earlier pharma focus, and come to the cannabis party a little…
-
![How Sixth Wave (SIXW.C) plans to “protect and detect” for COVID-19]()
How Sixth Wave (SIXW.C) plans to “protect and detect” for COVID-19
Sixth Wave is a nanotechnology company focusing on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs).
-
![Isracann’s (IPOT.C) export strategy just got a green light]()
Isracann’s (IPOT.C) export strategy just got a green light
October 14, 2020 Isracann announced that “the government of Israel has officially enacted the legislation for the export of medical cannabis, clearing the way for sales abroad that the government expects could generate more than 1 billion shekels ($273 million) in annual revenue.”
-
Revive (RVV.C) gives update on FDA Phase 3 clinical trial
Given the grim human and financial data, it’s no surprise that biotech companies and their shareholders are focused on developing coronavirus solutions.
-
![Xphyto (XPHY.C) advances its Oral Dissolvable Film (ODF) technology for CBD and THC medical markets]()
Xphyto (XPHY.C) advances its Oral Dissolvable Film (ODF) technology for CBD and THC medical markets
Increased product efficacy and patient convenience is anticipated through faster onset of drug action, more predictable therapeutic activity and ease of use.
-
![Xphyto (XPHY.C) updates shareholders on rapid COVID-19 (SARS-CoV-2) screening test]()
Xphyto (XPHY.C) updates shareholders on rapid COVID-19 (SARS-CoV-2) screening test
Xphyto and 3a are developing rapid screening tests for COVID-19 and other high-risk pandemic threats, including H1N1 (swine flu) and H5N1 (avian flu), with a specific focus on early pre-symptomatic and asymptomatic stages of infection
-
![That was quick: Valeo Pharma (VPH.C) gets Health Canada nod for immune system booster]()
That was quick: Valeo Pharma (VPH.C) gets Health Canada nod for immune system booster
“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it could “potentially fight off symptoms associated with coronaviruses.”
-
![PredictMedix (PMED.C) to deploy its COVID-19 screening tech in Texas]()
PredictMedix (PMED.C) to deploy its COVID-19 screening tech in Texas
Institutional failure at every level of decision making in the United States is why COVID-19 in the world’s largest economy is neither contained nor controlled. A healthy reminder – no matter how bad things are, they can always get worse. With over 6 million active cases and 186K+ deaths, the pandemic is a nightmare that…
-
![Isracann (IPOT.C) and Tinley (TNY.C) update shareholders on production profile]()
Isracann (IPOT.C) and Tinley (TNY.C) update shareholders on production profile
Isracann and Tinley update shareholders
-
Revive’s (RVV.C) Bucillamine Covid-19 treatment advances through development pipeline
Given the grim human and financial data, it’s no surprise that biotech companies and their shareholders are focussed on developing coronavirus solutions.
